Eva Lion
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 51
- Immunotherapy and Immune Responses 41
- Immune Cell Function and Interaction 30
- T-cell and B-cell Immunology 13
- Oncology 32
- CAR-T cell therapy research 29
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Evelien Smits (40 shared papers)Viggo Van Tendeloo (38 shared papers)Zwi Berneman (38 shared papers)Sébastien Anguille (32 shared papers)Yannick Willemen (14 shared papers)Diana Campillo-Davó (17 shared papers)Heleen H. Van Acker (8 shared papers)Jorrit De Waele (5 shared papers)
- Journals
- Frontiers in Immunology (5 papers)Cancers (5 papers)Oncotarget (5 papers)PLoS ONE (5 papers)Cytotherapy (3 papers)
- Partner nations
- BelgiumUgandaNetherlands
In The Last Decade
Eva Lion
60 papers receiving 2.6k citations
Eva Lion's Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 1.9k
- Oncology 1.3k
- Hematology 277
- Molecular Biology 731
- Biotechnology 87
Countries citing papers authored by Eva Lion
This map shows the geographic impact of Eva Lion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lion more than expected).
Fields of papers citing papers by Eva Lion
This network shows the impact of papers produced by Eva Lion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lion. The network helps show where Eva Lion may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Lion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical use of dendritic cells for cancer therapy Hit paper breakdown → | 2014 | 541 |
| 2 | 2014 | 140 | |
| 3 | 2012 | 126 | |
| 4 | 2020 | 123 | |
| 5 | 2015 | 122 | |
| 6 | 2016 | 98 | |
| 7 | 2019 | 89 | |
| 8 | 2011 | 88 | |
| 9 | 2018 | 75 | |
| 10 | 2012 | 68 | |
| 11 | 2019 | 61 | |
| 12 | 2020 | 57 | |
| 13 | 2017 | 56 | |
| 14 | 2009 | 54 | |
| 15 | 2015 | 52 | |
| 16 | 2019 | 50 | |
| 17 | 2012 | 48 | |
| 18 | 2015 | 47 | |
| 19 | 2012 | 47 | |
| 20 | 2017 | 45 |
About Eva Lion
Eva Lion is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 64 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (30 papers), CAR-T cell therapy research (29 papers), T-cell and B-cell Immunology (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), RNA Interference and Gene Delivery (7 papers), Virus-based gene therapy research (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Immunology (1.9k citations), Oncology (1.3k citations), Hematology (277 citations), Molecular Biology (731 citations) and Biotechnology (87 citations). Eva Lion has collaborated with scholars based in Belgium, Uganda and Netherlands. Frequent co-authors include Evelien Smits, Viggo Van Tendeloo, Zwi Berneman, Sébastien Anguille, Yannick Willemen, Diana Campillo-Davó, Heleen H. Van Acker, Jorrit De Waele, Herman Goossens and Elly Marcq. Their work appears in journals such as Frontiers in Immunology, Cancers, Oncotarget, PLoS ONE and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.